Patterns of amygdala region pathology in LATE-NC: subtypes that differ with regard to TDP-43 histopathology, genetic risk factors, and comorbid pathologies Matthew D. CykowskiAnithachristy S. ArumanayagamPeter T. Nelson Original Paper Open access 02 April 2022 Pages: 531 - 545
Wolframin is a novel regulator of tau pathology and neurodegeneration Shuo ChenDiana AcostaHongjun Fu Original Paper 07 April 2022 Pages: 547 - 569
Tau polygenic risk scoring: a cost-effective aid for prognostic counseling in Alzheimer’s disease Vijay K. RamananMichael G. HeckmanPrashanthi Vemuri Original Paper 12 April 2022 Pages: 571 - 583
Proteomic differences in hippocampus and cortex of sudden unexplained death in childhood Dominique F. LeitnerChristopher WilliamOrrin Devinsky Original Paper Open access 25 March 2022 Pages: 585 - 599
Donanemab detects a minor fraction of amyloid-β plaques in post-mortem brain tissue of patients with Alzheimer’s disease and Down syndrome Yvonne BouterHendrik LiekefeldThomas A. Bayer Correspondence Open access 16 April 2022 Pages: 601 - 603
Somatic LINE-1 promoter acquisition drives oncogenic FOXR2 activation in pediatric brain tumor Diane A. FlaschXiaolong ChenJinghui Zhang Correspondence Open access 11 April 2022 Pages: 605 - 607
Rapid-CNS2: rapid comprehensive adaptive nanopore-sequencing of CNS tumors, a proof-of-concept study Areeba PatelHelin DoganFelix Sahm Correspondence Open access 31 March 2022 Pages: 609 - 612